A randomized controlled clinical trial on irinotecan/cisplatin versus gemcitabine/cisplatin as the first-line treatment in advanced non-small cell lung cancer / 中国癌症杂志
China Oncology
;
(12)2006.
Artículo
en Chino
| WPRIM
| ID: wpr-545488
ABSTRACT
0.05).The incidence rate of diarrhea in IP group was 48.4% it was significantly higher than GP group(P
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Ensayo Clínico Controlado
Idioma:
Chino
Revista:
China Oncology
Año:
2006
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS